5 unknown, 3 recruiting. 7 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Unknown 5, Recruiting 2 |
| Phase 2 | 6 | Recruiting 3, Unknown 3 |
Follow T3011: new trials by email Literature Review of T3011 trials Research Report on T3011
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC T3011 - Nonmuscle-invasive Bladder Cancer | Phase 2 | Recruiting | ImmVira Pharma Co. Ltd | 160 | 2025-06-09 | 2026-08-18 |
| A Clinical Study of T3011 in Subjects With Advanced Melanoma T3011 - Advanced Melanoma | Phase 1 / Phase 2 | Recruiting | Shanghai Pharmaceuticals Holding Co., Ltd | 42 | 2024-01-26 | 2026-08-06 |
| A Clinical Study of Intraperitoneal T3011 Given as a Single Agent in Patients With Malignant Ascites Induced by Advanced Colorectal Cancer T3011 - Malignant Ascites | Phase 1 | Unknown | West China Hospital | 10 | 2023-09-28 | 2024-01-11 |
| A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer T3011, Regorafenib - Advanced Colorectal Cancer | Phase 1 | Unknown | West China Hospital | 15 | 2023-09-21 | 2024-01-11 |
| A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. T3011 - Advanced Solid Tumor, Lung Cancer | Phase 1 / Phase 2 | Unknown | ImmVira Pharma Co. Ltd | 74 | 2022-03-01 | 2022-10-28 |
| Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors T3011 - Solid Tumor, Hepatocellular Carcinoma | Phase 1 / Phase 2 | Unknown | ImmVira Pharma Co. Ltd | 42 | 2021-08-10 | 2024-03-04 |
| A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors T3011, T3011 + pembrolizumab - Solid Tumor, Melanoma | Phase 1 / Phase 2 | Recruiting | ImmVira Pharma Co. Ltd | 30 | 2020-09-17 | 2025-10-08 |
| A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors T3011 - Advanced Solid Tumor, Sarcoma | Phase 1 / Phase 2 | Unknown | ImmVira Pharma Co. Ltd | 233 | 2020-04-21 | 2022-11-02 |
Sarcoma (2) · Squamous Cell Carcinoma of Head and Neck (2) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Squamous Cell (1) · Colorectal Neoplasms (1) · Endometrial Neoplasms (1) · Esophageal Neoplasms (1) · Liver Neoplasms (1) · Lung Neoplasms (1) · Lymphoma (1) · Melanoma (1) · Mesothelioma, Malignant (1) · Ovarian Neoplasms (1)
ImmVira Pharma Co. Ltd (5) · West China Hospital (2) · Shanghai Pharmaceuticals Holding Co., Ltd (1)
China (5) · United States (3) · Australia (1)